Zai Lab Announces First Patient Treated in China in the Registrational Phase 2 TRIDENT-1 Study of Repotrectinib - TC Read more about Zai Lab Announces First Patient Treated in China in the Registrational Phase 2 TRIDENT-1 Study of Repotrectinib - TC
Zai Lab Announces Upcoming Presentations in June Investor Conferences - TC Read more about Zai Lab Announces Upcoming Presentations in June Investor Conferences - TC
Zai Lab Announces First Patient Treated in Greater China in METIS Phase 3 Pivotal Trial of Tumor Treating Fields in Brain Metastases from Non-Small Cell Lung Cancer - TC Read more about Zai Lab Announces First Patient Treated in Greater China in METIS Phase 3 Pivotal Trial of Tumor Treating Fields in Brain Metastases from Non-Small Cell Lung Cancer - TC
Zai Lab Announces First Quarter 2021 Financial Results - TC Read more about Zai Lab Announces First Quarter 2021 Financial Results - TC
Zai Lab to Announce First Quarter 2021 Financial Results on May 10, 2021 - TC Read more about Zai Lab to Announce First Quarter 2021 Financial Results on May 10, 2021 - TC
Zai Lab Announces Closing of Public Offering of American Depositary Shares and Full Exercise of Greenshoe Option - TC Read more about Zai Lab Announces Closing of Public Offering of American Depositary Shares and Full Exercise of Greenshoe Option - TC
Zai Lab Announces Pricing of Public Offering of American Depositary Shares and Ordinary Shares - TC Read more about Zai Lab Announces Pricing of Public Offering of American Depositary Shares and Ordinary Shares - TC
Zai Lab Announces Proposed Public Offering of American Depositary Shares - TC Read more about Zai Lab Announces Proposed Public Offering of American Depositary Shares - TC
Zai Lab Partner Novocure Announces Update on Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in Non-Small Cell Lung Cancer - TC Read more about Zai Lab Partner Novocure Announces Update on Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in Non-Small Cell Lung Cancer - TC
China NMPA Approves QINLOCK® (Ripretinib) for Treatment of Advanced Gastrointestinal Stromal Tumors (GIST) - TC Read more about China NMPA Approves QINLOCK® (Ripretinib) for Treatment of Advanced Gastrointestinal Stromal Tumors (GIST) - TC